Philippe Selhorst

Medicine & Life Sciences

1. HIV-1 100%
2. Disease Outbreaks 92%
3. Anti-Infective Agents 82%
4. Severe Acute Respiratory Syndrome 59%
5. Coronavirus 58%
6. Reverse Transcriptase Inhibitors 55%
7. Viruses 52%
8. Monkeypox virus 39%
9. Mutation 35%
10. Infection 34%
11. Niger 34%
12. SARS Virus 34%
13. Belgium 32%
14. Chikungunya virus 32%
15. Annual Reports 31%
16. Democratic Republic of the Congo 31%
17. AIDS Vaccines 29%
18. Male Genitalia 29%
19. Peru 29%
20. Asian Americans 28%
21. Dengue Virus 27%
22. HIV 27%
23. Sexual Health 27%
24. Dengue 26%
25. MIV-160 25%
26. Rituximab 25%
27. Culicidae 24%
28. Allergy and Immunology 24%
29. Binding Sites 23%
30. Congresses 22%
31. Neutralizing Antibodies 22%
32. Virion 21%
33. Aedes 21%
34. Serogroup 21%
35. Antibody Formation 20%
36. Health Personnel 20%
37. Antiviral Agents 19%
38. Blood Cells 17%
39. Virus Diseases 16%
40. Kinetics 16%
41. Genotype 16%
42. UC 781 14%
43. Education 14%
44. Military Personnel 14%
45. Genitalia 13%
46. In Vitro Techniques 13%
47. Genome 11%
48. Humoral Immunity 11%
49. immunoglobulin A, immunoglobulin G, immunoglobulin M drug combination 10%
50. Vaccines 10%